Ablating N-Acetylaspartate Prevents Leukodystrophy in a Canavan Disease Model
2015
Canavan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous system (CNS) NAA and progressively worsening leukodystrophy. We now report that ablating NAA synthesis by constitutive genetic disruption of Nat8l (N-acetyltransferase-8 like) permits normal CNS myelination and prevents leukodystrophy in a murine Canavan disease model. Ann Neurol 2015;77:884–888
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
34
Citations
NaN
KQI